Cell death mechanisms associated with G2 radiosensitivity in patients with prostate cancer and benign prostatic hyperplasia

Radiation Research

Volumn 164, Issue 5, 2005, Pages 627-634

  Howe, Orla ^a   O'Malley, Kiaran ^b   Lavin, Martin ^c   Gardner, Robert A ^c   Seymour, Colin ^d,e   Lyng, Fiona ^a   Mulvin, David ^b   Quinlan, David M ^b   Mothersill, Carmel ^a  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d ST LUKE S HOSPITAL   (Ireland)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD SAMPLING; CELL CYCLE; CELL CYCLE G2 PHASE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DNA DAMAGE; HUMAN; HUMAN CELL; MALE; METAPHASE; MITOSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RADIATION INJURY; RADIOSENSITIVITY; TETRAPLOIDY;

AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; DNA REPAIR; G2 PHASE; HUMANS; MALE; MIDDLE AGED; MITOSIS; POLYPLOIDY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RADIATION TOLERANCE;

EID: 27444439663     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3454.1     Document Type: Article

References (38)

1. E. J. Hall, Radiobiology for the Radiologist, 5th ed. Lippincott Williams and Wilkins, Philadelphia, PA, 2000.
2. D. C. Lloyd, G. W. Dolphin, R. J. Purrott and P. A. Tipper, The effect of x-ray induced mitotic delay on chromosome aberration yields in human lymphocytes. Mutat. Res. 42, 401-412 (1977).
3. J. S. Bedford and M. N. Cornforth, Relationship between the recovery from sublethal X-ray damage and the rejoining of chromosome breaks in normal human fibroblasts. Radiat. Res. 111, 406-423 (1987).
4. 2 chromatin radiosensitivity in predisposition to cancer. Int. J. Radiat. Biol. 55, 963-981 (1989).
5. D. Scott, J. P. B. Barber, A. R. Spreadborough, W. Burrill and S. A. Roberts, Increased chromosomal radiosensitivity in breast cancer patients: A comparison of two assays. Int. J. Radiat. Biol. 75, 1-10 (1999).
6. D. Scott, A. Spreadborough, E. Levine and S. A. Roberts, Genetic predisposition to breast cancer. Lancet 344, 1444 (1994).
7. R. Parshad, F. M. Price, V. A. Bohr, K. H. Cowans, J. A. Zujewski and K. K. Sanford, Deficient DNA repair capacity, a predisposing factor in breast cancer. Br. J. Cancer 74, 1-5 (1996).
8. R. K. Patel, A. Trivedi, D. Arora, J. M. Bhatavdekar and D. D. Patel, DNA repair proficiency in breast cancer patients and their first-degree relatives. Int. J. Cancer 73, 20-24 (1997).
9. K. Baria, C. Warren, S. A. Roberts, C. M. West and D. Scott, Chromosomal radiosensitivity as a marker of predisposition to common cancers? Br. J. Cancer 84, 892-896 (2001).
10. A. Baeyens, H. Thierens, K. Claes, B. Poppe, L. Messiaen, L. De Ridder and A. Vral, Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br. J. Cancer 87, 1379-1385 (2002).
11. 2-phase lymphocytes identifies breast cancer patients with distinctive tumour characteristics. Br. J. Cancer 85, 1157-1161 (2001).
12. 2 chromosomal radiosensitivity in Irish breast cancer patients: A comparison with other studies. Int. J. Radiat. Biol., in press.
13. R. Papworth, W. Slevin, S. A. Roberts and D. Scott, Sensitivity to radiation-induced chromosomal damage may be a marker of genetic predisposition in young head and neck cancer patients. Br. J. Cancer 84, 776-782 (2001).
14. P. E. Bryant, The signal model: a possible explanation for the conversion of DNA double-strand breaks into chromatid breaks. Int. J. Radiat. Biol. 73, 243-251 (1998).
15. 2 chromosomal radiosensitivity in cancer patients: The role of cdk 1/cyclin-B activity level in the mechanisms involved. Int. J. Radiat. Biol. 61, 777-784 (2000).
16. 2 and spindle assembly checkpoint adaptation, and tetraploidy arrest: Implications for intrinsic and chemically induced genomic instability. Mutat. Res. 532, 245-253 (2003).
17. 1 in response to actin inhibition is dependent on retinoblastoma pocket proteins but not P53. J. Cell Biol. 161, 67-77 (2003).
18. 1 phase of the cell cycle, and specific-related mortality of transformed cells. J. Cell Biol. 135, 689-700 (1996).
19. 2-M transition in vertebrates. Curr. Biol. 10, 1067-1070 (2000).
20. D. A. Soufias, P. R. Andreassen, F. B. Lacroix, L. Wilson and R. L. Margolis, Mammalian mad2 and bub1/bubR1 recognize distinct spindle-attachment and kinetochore-tension checkpoints. Proc. Natl. Acad. Sci. USA 98, 4492-4497 (2001).
21. J. Erenpreisa and M. S. Cragg, Mitotic death: A mechanism of survival? A review. Cancer Cell Int. 1, 1 (2003).
22. E. I. Miranda, C. Sanatan, E. Rojas, A. Hernandez, P. Ostroskey-Wegman and A. Garcia-Carrance, Induced mitotic death of HeLa cells by abnormal expression of c-H-ras. Mutat. Res. 349, 173-182 (1996).
23. P. L. Olive, G. Frazer and J. P. Banath, Radiation-induced apoptosis measured in TK6 human B lymphoblast cells using the comet assay. Radiat. Res. 136, 130-136 (1993).
24. P. L. Olive and R. E. Durand, Apoptosis: An indicator of radiosensitivity in vitro? Int. J. Radiat. Biol. 71, 695-707 (1997).
25. A. Ivanov, M. S. Cragg, J. Erenpreisa, D. Emzinsh, H. Lukman and T. M. Illidge, Endopolyploid cells produced after severe genotoxic damage have the potential to repair DNA double strand breaks. J. Cell Sci. 116, 4095-4106 (2003).
26. 2 arrest in irradiated cells of breast cancer patients than in female controls: A contribution to their enhanced chromosomal radiosensitivity? Int. J. Radiat. Biol. 79, 405-411 (2003).
27. 1. Mol. Biol. Cell 12, 1315-1328 (2001).
28. P. R. Andreassen, S. N. Martineau and R. L. Margolis, Chemical induction of mitotic checkpoint override in mammalian cells results in aneuploidy following a transient tetraploid state. Mutat. Res. 372, 181-194 (1996).
29. A. J. Minn, L. H. Boice and C. B. Thompson, Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev. 10, 2621-2631 (1996).
30. J. S. Lanni and T. Jacks, Characterisation of the p53-dependent post-mitotic checkpoint following spindle disruption. Mol. Cell Biol. 18, 1055-1064 (1998).
31. Z. A. Stewart, S. D. Leach and J. A. Pietenpol, p21 (Waf1/Cip1) inhibition of cyclin E/CDK2 activity prevents endoreduplication after mitotic spindle disruption. Mol. Cell Biol. 19, 205-215 (1999).
32. D. W. Russell and J. D. Wilson, Steroid 5 alpha-reductase: Two genes/two enzymes. Annu. Rev. Biochem. 63, 25-61 (1994).
33. P. B. Grino, J. E. Griffen and J. D. Wilson, Testosterone at high concentrations interacts with human androgen receptor similarly to dihydrotestosterone. Endocrinology 126, 1165-1172 (1990).
34. 2 chromatid aberrations but not with adaptive response. Mutagenesis 15, 531-535 (2000).
35. S. A. Roberts, A. R. Spreadborough, B. Bulman, S. B. P. Barber, D. G. R. Evans and D. Scott, Heritability of cellular radiosensitivity: A marker of low penetrance predisposition genes in breast cancer. Am. J. Hum. Genet. 65, 784-794 (1999).
36. 2 phase x-irradiation of cells from cancer-prone individuals implicates deficiency in DNA repair. Proc. Natl. Acad. Sci. USA 80, 5612-5616 (1983).
37. 2 checkpoint and anticancer therapy. In Cell Cycle Checkpoints and Cancer (M. V. Blagosklonny, Ed.), pp. 155-178. Landes Bioscience, Georgetown, TX, 2002.
38. I. B. Roninson, E. V. Broude and B-D. Chang, If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist. Updat. 4, 303-313 (2002).